BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
NEUROG3
,
T cell receptor signaling pathway
,
Obesity
,
Pancreas
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cyp3A
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Prostate cancer
Malignant tumor of muscle
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Gene expression profiling of prostate cancer
Gene Expression Profiles of Head and Neck Squamous Cell Carcinoma (HNSCC) primary tumors
Gene expression profiling of children affected by Alveolar Rhabdomyosarcoma (ARMS)
Explore Curated Studies Results
Literature
Most Relevant Literature
Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Backg…
Tiered approach to evaluate the CYP3A victim and perpetrator drug-drug interaction potential for von…
CYP3A inhibitors as a pharmacokinetic enhancer: pros and cons of drug interactions].
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or stron…
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Buprenorphine Disposition and CYP3A
Fruquintinib CYP3A Inhibitor and Inducer Study
Surufatinib DDI With a PPI and a CYP3A Inducer
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ